BOLD

2.84

0.35% -0.01

Dopo l'orario di chiusura: 2.84

Boundless Bio Inc (BOLD)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$2.85

Aprire:

$2.85

Volume 24 ore:

28,654

Relative Volume:

0.02

Capitalizzazione di mercato:

$64.60M

Reddito:

Utile/perdita netta:

$-55.99M

Rapporto P/E:

-1.1354

EPS:

-2.5013

Flusso di cassa netto:

$-47.60M

1 W Prestazione:

-1.05%

1M Prestazione:

+0.71%

6M Prestazione:

+146.96%

1 anno Prestazione:

+144.83%

Intervallo 1D:

$2.82

$2.87

Intervallo di 1 settimana:

$2.76

$2.94

Portata 52W:

$0.9612

$3.1636

Boundless Bio Inc Stock (BOLD) Company Profile

Nome

Boundless Bio Inc

Settore

Healthcare (1069)

Industria

Biotechnology (595)

Telefono

(858) 766-9912

Indirizzo

10955 ALEXANDRIA WAY, SAN DIEGO

Dipendente

Cinguettio

Prossima data di guadagno

2026-11-04

Ultimi documenti SEC

BOLD's Discussions on Twitter

Compare BOLD vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BOLD Boundless Bio Inc	2.84	64.83M	0	-55.99M	-47.60M	-2.5013
VRTX Vertex Pharmaceuticals Inc	514.56	132.08B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	793.26	83.15B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	984.04	62.71B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	136.62	54.14B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	203.35	44.51B	742.00K	-1.37B	-1.07B	-7.0731

Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-02	Iniziato	H.C. Wainwright	Buy
2025-05-28	Downgrade	Leerink Partners	Outperform → Market Perform
2024-12-13	Downgrade	Guggenheim	Buy → Neutral
2024-04-22	Iniziato	Guggenheim	Buy
2024-04-22	Iniziato	Leerink Partners	Outperform
2024-04-22	Iniziato	Piper Sandler	Overweight

Mostra tutto

Boundless Bio Inc Borsa (BOLD) Ultime notizie

Sep 07, 2026

Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today - Stocktwits

Sep 07, 2026

Sep 03, 2026

TANG KEVIN C Trims Boundless Bio Inc (BOLD) Stake Amid Volatile Trading - GuruFocus

Sep 03, 2026

Boundless Bio (BOLD) Q2 2026 Earnings: Wider-than-Expected Loss of $1.06 per Share Pressures the Stock - dars.gov.et

Sep 03, 2026

Aug 31, 2026

Boundless Bio (NASDAQ: BOLD) Updates Serapha Merger with 19.99% Ownership Cap and Revised Voting Rules - Kalkine Media

Aug 31, 2026

Aug 28, 2026

Boundless Bio Amends Merger Agreement with Serapha Bio - TipRanks

Aug 28, 2026

Boundless Bio (NASDAQ: BOLD) adds $0.00001 warrants to cap ownership in Serapha deal - Stock Titan

Aug 28, 2026

Kevin Tang group trims Boundless Bio (BOLD) stake, returns profit - Stock Titan

Aug 28, 2026

2,426,857 Boundless Bio (NASDAQ: BOLD) shares held by Zachary Hornby - Stock Titan

Aug 28, 2026

Aug 24, 2026

Boundless (BOLD) Financial Update: Profit Per Share Falls Below Its Benchmark in the Reported Period - vinanet.vn

Aug 24, 2026

Aug 20, 2026

Boundless (BOLD) Session: Climbs 1.40% to $2.90 in the Current Update; Trading Range: Price Remains Between $2.75 Support and $3.04 Resistance on the DayFactor Timing - vinanet.vn

Aug 20, 2026

Boundless (BOLD) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Shares Show Limited Movement under the Current SnapshotFiscal Year Earnings - vinanet.vn

Aug 20, 2026

Aug 14, 2026

Boundless Bio (BOLD): ADAR1 Capital discloses 8.8% beneficial ownership stake - Stock Titan

Aug 14, 2026

Boundless Bio (BOLD): Citadel entities and Ken Griffin report 0.6% ownership - Stock Titan

Aug 14, 2026

Aug 13, 2026

Boundless Bio (BOLD) Edges Up to $2.79 as Stock Holds Tight Trading RangeTriple Bottom - Vinanet

Aug 13, 2026

Aug 07, 2026

Boundless Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 07, 2026